Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29942
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vermersch, P. | - |
dc.contributor.author | Eralinna, J. -P. | - |
dc.contributor.author | Nicholas, R. | - |
dc.contributor.author | Oreja-Guevara, C. | - |
dc.contributor.author | Siva, A. | - |
dc.contributor.author | VAN WIJMEERSCH, Bart | - |
dc.contributor.author | Wiendl, H. | - |
dc.contributor.author | Buffels, R. | - |
dc.contributor.author | Kuhelj, R. | - |
dc.contributor.author | Wei, W. | - |
dc.contributor.author | Comi, G. | - |
dc.date.accessioned | 2019-11-13T08:30:13Z | - |
dc.date.available | 2019-11-13T08:30:13Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | MULTIPLE SCLEROSIS JOURNAL, 25(SI), p. 344-345 (Art N° P690) | - |
dc.identifier.issn | 1352-4585 | - |
dc.identifier.uri | http://hdl.handle.net/1942/29942 | - |
dc.description.sponsorship | Sponsored by F. Hoffmann-La Roche Ltd; writing and editorial assistance was provided by Articulate Science, UK. P. Vermersch has received honoraria and consulting fees from Bayer, Biogen, Celgene, MedDay, Merck, Novartis, Roche, Sanofi Genzyme, Servier, Teva and Almirall, and research support from Bayer, Biogen, Merck, Novartis, Roche and Sanofi Genzyme. | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.subject.other | Clinical Neurology; Neurosciences | - |
dc.title | Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a suboptimal response to previous disease-modifying therapies (1-year interim results) | - |
dc.type | Journal Contribution | - |
local.bibliographicCitation.conferencedate | SEP 11-13, 2019 | - |
local.bibliographicCitation.conferencename | 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS | - |
local.bibliographicCitation.conferenceplace | Stockholm, SWEDEN | - |
dc.identifier.epage | 345 | - |
dc.identifier.issue | SI | - |
dc.identifier.spage | 344 | - |
dc.identifier.volume | 25 | - |
local.format.pages | 2 | - |
local.bibliographicCitation.jcat | M | - |
dc.description.notes | [Vermersch, P.] Univ Lille, Lille, France. [Eralinna, J. -P.] NEO Res, Turku, Finland. [Nicholas, R.] Imperial Coll Healthcare NHS Trust, London, England. [Nicholas, R.] Imperial Coll, London, England. [Oreja-Guevara, C.] Hosp Clin San Carlos, Madrid, Spain. [Siva, A.] Istanbul Univ, Cerrahpasa Sch Med, Cerrahpasa, Turkey. [Van Wijmeersch, B.] Univ Hasselt, Overpelt, Belgium. [Van Wijmeersch, B.] Rehabil & MS Ctr Overpelt, Overpelt, Belgium. [Wiendl, H.] Univ Munster, Munster, Germany. [Buffels, R.; Kuhelj, R.; Wei, W.] F Hoffmann La Roche Ltd, Basel, Switzerland. [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. | - |
local.publisher.place | LONDON | - |
local.type.refereed | Refereed | - |
local.type.specified | Meeting Abstract | - |
local.bibliographicCitation.artnr | P690 | - |
local.class | dsPublValOverrule/author_version_not_expected | - |
dc.identifier.isi | 000485303101246 | - |
item.accessRights | Closed Access | - |
item.fulltext | No Fulltext | - |
item.fullcitation | Vermersch, P.; Eralinna, J. -P.; Nicholas, R.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Buffels, R.; Kuhelj, R.; Wei, W. & Comi, G. (2019) Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a suboptimal response to previous disease-modifying therapies (1-year interim results). In: MULTIPLE SCLEROSIS JOURNAL, 25(SI), p. 344-345 (Art N° P690). | - |
item.contributor | Vermersch, P. | - |
item.contributor | Eralinna, J. -P. | - |
item.contributor | Nicholas, R. | - |
item.contributor | Oreja-Guevara, C. | - |
item.contributor | Siva, A. | - |
item.contributor | VAN WIJMEERSCH, Bart | - |
item.contributor | Wiendl, H. | - |
item.contributor | Buffels, R. | - |
item.contributor | Kuhelj, R. | - |
item.contributor | Wei, W. | - |
item.contributor | Comi, G. | - |
crisitem.journal.issn | 1352-4585 | - |
crisitem.journal.eissn | 1477-0970 | - |
Appears in Collections: | Research publications |
WEB OF SCIENCETM
Citations
1
checked on Apr 16, 2024
Page view(s)
76
checked on Jul 31, 2023
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.